
There have been two noteworthy discoveries from a recent randomized controlled trial conducted by Dr. Urban Alehagen of Linköping University (Sweden) and his colleagues.
Firstly, people with low concentrations of selenium in their blood were found to be at significantly higher risk of death from heart disease.
Secondly, a combination of a patented high selenium yeast supplement and a proven Coenzyme Q10 supplement taken daily for four years provided significant protection against heart disease in people with low serum selenium status.
The KiSel-10 study of cardiovascular mortality
The study enrolled 668 healthy elderly individuals aged 70-80 years. The study was well-designed and well-executed. One group of 219 randomly selected individuals received 200 micrograms of selenized yeast tablets and 200 milligrams of Coenzyme Q10 capsules daily for four years. A second randomly assigned group of 222 individuals received matching placebos. The remaining group of 227 individuals received no treatment at all.